FLASH NEWS LIVE

Novo to track generic surge as semaglutide goes off patent

Novo to track generic surge as semaglutide goes off patent

Novo Nordisk is preparing for a surge of generic semaglutide drugs in India. The company's India head stated they will monitor rivals' pricing and market strategies closely. With many companies launching cheaper versions, Novo Nordisk plans to evaluate the market before reacting. This move comes as the blockbuster diabetes and weight-loss drug's patent expires.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp